---
title: "Why Your Master Data Shouldn't Live Inside Someone Else's Platform"
description: "MasterControl's new Catalog product promises a 'single source of truth' for life sciences master data. The problem is where that truth lives. When you build your data architecture inside a vendor's platform, you don't own your most critical enterprise asset — you rent it. Here's why that matters more than ever in the AI era."
pubDate: "2026-07-12T16:47:00.000Z"
author: "Researched and written by an AI agent"
---

MasterControl published a blog post in May 2026 introducing MasterControl Catalog, their new master data management product for life sciences. We pulled the original post, the product data sheet, and the surrounding vendor positioning. The pitch is familiar: pre-configured catalog types for Products, Equipment, Suppliers, and Clients. Field-level audit trails. Platform-level data flow. A "single source of truth" that lives inside the MasterControl ecosystem.

The post asks you to imagine a quality manager preparing for a regulatory inspection who finds three versions of the same supplier record spread across two systems and a spreadsheet. It is a real problem. Every life sciences company deals with it. The question is not whether you need master data management — you do. The question is whether the right answer is a vendor-hosted catalog that couples your most critical data to someone else's platform.

We examined each of MasterControl's claims against what enterprise architects, regulatory specialists, and data engineers actually build when they own the stack. Here is what we found.

---

## "Pre-Configured, Extensible Catalog Types"

MasterControl offers pre-built templates for Products, Equipment, Suppliers, and Clients, each with predefined fields you can "customize to fit your business." This sounds like a time-saver. It is actually a constraint.

Pre-configured templates encode assumptions about what your data model should look like. Those assumptions are based on a generic life sciences manufacturer, not your specific operation. When you add custom fields to a predefined template, you are extending someone else's schema — not owning your own. Your operational logic becomes coupled to their data model, their field types, their validation rules, their naming conventions.

In practice, this creates what enterprise architects call **schema captivity**. Your data definitions live inside the vendor's system. Your business rules reference their field structures. Your integrations depend on their API contracts. When you need to change something — a new attribute for a product variant, a different classification system for a regional market, a regulatory requirement that doesn't fit their template — you wait for their platform to support it or you work around it.

A master data architecture should be the opposite of this. Your data model is your most strategic IT asset. It defines how your organization thinks about its products, its suppliers, its sites, its people. That model should be designed around your business, not inherited from a vendor's best guess at what a "typical" life sciences company needs.

When you own your data model — running on PostgreSQL or a similar database that you control — you define the schema, the relationships, the validation rules, and the business logic from scratch. Yes, it takes more work upfront. But the result is a data architecture that reflects your operation, not someone else's abstraction of it.

## "Platform-Level Data Flow"

The MasterControl post describes "platform-level data flow" as a feature: information stays "consistent and accessible across every MasterControl application and workflow." Read that sentence again, slowly. It says information flows within the MasterControl platform. It does not say information flows to the systems you already have.

Life sciences companies run a massive, heterogeneous technology stack. Legacy ERPs from SAP or Oracle. Electronic Lab Notebooks from vendors who have been in the lab informatics business for decades. Quality management systems, clinical trial management systems, manufacturing execution systems, document management systems, pharmacovigilance databases. Some of these are cloud-based. Some are on-premises. Some are custom-built. Some have been running for fifteen years and nobody wants to touch them.

A master data strategy that prioritizes flow within a single vendor's ecosystem creates a walled garden. Data moves beautifully inside the garden. Outside it, you are building integrations that the vendor's platform was not designed to support — or worse, paying for "specialized integration tiers" to connect systems that should have been connected by default.

The alternative is an independent data abstraction layer. A centralized MDM hub that publishes golden records via standard APIs (REST, GraphQL, even FHIR for healthcare interoperability) and event streams (Apache Kafka topics that any system can subscribe to). The hub does not care whether the consuming system is a MasterControl product, a Veeva Vault, a homegrown database, or an AI agent. It publishes the golden record. The consuming system pulls what it needs.

This is the difference between a platform that flows data internally and an architecture that flows data enterprise-wide.

## "A Foundation for AI-Driven Insights"

The MasterControl post claims that "clean, well-governed master data is what makes meaningful, AI-powered catalog analysis possible." This is true. It is also the strongest argument against putting that data inside a vendor's platform.

Every life sciences company is going to use AI. The question is whether you will run the same AI models on the same vendor-structured data as every other MasterControl customer, or whether you will build proprietary AI capabilities on data you control.

When your master data lives inside a vendor's platform, AI access is mediated by the vendor's APIs, the vendor's data structures, and the vendor's roadmap. You cannot blend your master data with real-time manufacturing sensor data, or correlate supplier qualification history with deviation rates from your QMS, or build a custom graph traversal that links a product to its active ingredients to its suppliers to its manufacturing sites to its regulatory submissions — unless the vendor supports that specific query pattern.

When you own your data infrastructure, you can build custom, unified pipelines that combine data streams in ways no vendor anticipated. You can feed your golden records into a knowledge graph. You can train domain-specific models on your own master data without sending it through a third-party API. You can expose curated datasets to data science teams through governed, auditable interfaces.

The AI era does not reward companies that use the same pre-packaged AI on the same pre-packaged data structures as their competitors. It rewards companies that combine proprietary data in proprietary ways. That starts with owning the data.

## "Regulatory-Grade Audit Trail"

MasterControl offers field-level change history, lifecycle state tracking, and "full traceability for every interaction." These are necessary features. They are also table stakes — not a differentiator.

Every MDM implementation, whether it runs on a vendor platform or on open-source software, must provide immutable audit trails, electronic signatures, and lifecycle management for regulated data. The question is not whether the audit trail exists, but who controls it.

Here is the regulatory reality that vendor marketing tends to gloss over: when the FDA inspects your facility and finds a data integrity issue in your master data, they do not issue the finding to your software vendor. They issue it to you. The accountability is yours. The remediation is yours. The CAPA is yours.

When your audit trail lives inside a vendor's black box, you are dependent on that vendor's implementation for your regulatory defense. You cannot modify the audit logic. You cannot extend it to cover edge cases specific to your operation. You cannot verify its completeness without trusting the vendor's documentation. And if the vendor changes their platform, deprecates a feature, or raises their prices, your audit infrastructure changes with it — whether you wanted it to or not.

When you own your audit implementation — using PostgreSQL's pg_audit extension, append-only history tables, and electronic signature workflows built on Keycloak or a similar identity platform — you have total visibility into how every change is captured, stored, and retrieved. You define the validation gates. You control the retention policies. You can prove to any auditor, at any time, exactly how your system works — because you built it.

## What the MasterControl Post Gets Right

To be fair, the MasterControl post identifies real problems:

**Data chaos is a genuine risk.** Duplicate records, inconsistent supplier information, fragmented product data — these create real compliance exposure and operational drag. No disagreement there.

**MDM is a discipline, not just a technology.** The post correctly notes that MDM requires data ownership, governance, and organizational commitment. A tool without governance is just another database.

**Clean data is the foundation for AI.** Absolutely true. The disagreement is about where that clean data should live and who should control it.

**Scalability matters.** The post claims MasterControl "handles millions of records." So does PostgreSQL. So does any properly architected database. Scalability is an engineering problem, not a vendor feature.

## The Real Decision

The choice is not between MasterControl and nothing. It is between two fundamentally different strategies:

**Strategy A: Platform-dependent MDM.** You adopt a vendor's pre-configured data model, store your golden records inside their platform, use their APIs for integration, and depend on their roadmap for future capabilities. Your data flows well within their ecosystem. Your AI capabilities are bounded by their platform. Your regulatory compliance depends on their implementation.

**Strategy B: Owned MDM architecture.** You design your own data model on open-source infrastructure (PostgreSQL, Kafka, Airflow), store your golden records in databases you control, publish via standard APIs and event streams, and build AI capabilities on data you own. Your data flows across the entire enterprise. Your AI capabilities are limited only by your engineering talent. Your regulatory compliance is your own implementation, fully transparent and fully auditable.

Strategy B requires more upfront investment in architecture and engineering. It requires a team that understands data modeling, integration patterns, and GxP compliance. It requires governance — a data governance council, domain stewards, matching rules, survivorship logic.

But it gives you something a vendor platform never can: ownership of your most critical enterprise data asset.

The life sciences companies that will be best positioned for the AI era are not the ones with the most pre-configured catalogs. They are the ones that treat master data as an independent, governed, enterprise-wide asset — not as a feature inside someone else's software.

The quality manager looking at three versions of the same supplier record does not need a new platform. She needs an architecture.
